cd9 marker proteins Search Results


90
Brickell Biotech cd9 marker proteins
Cd9 Marker Proteins, supplied by Brickell Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd9 marker proteins/product/Brickell Biotech
Average 90 stars, based on 1 article reviews
cd9 marker proteins - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GeneTex protein markers against cd9
Protein Markers Against Cd9, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein markers against cd9/product/GeneTex
Average 90 stars, based on 1 article reviews
protein markers against cd9 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
System Biosciences Inc cd9 protein marker
Classification and modification of human SMSCs and exosomes. (A): SMSCs exhibited a spindle‐like morphology. Scale bar = 50 μm. (B): Flow cytometric analysis of cell surface markers. Blank curves represent isotype controls and solid gray curves represent test samples. (C): SMSCs displayed osteogenic, adipogenic, and chondrogenic differentiation potential. Scale bars = 50 μm (osteogenic), 20 μm (adipogenic), and 100 μm (chondrogenic). (D): mRNA levels detected by quantitative reverse‐transcriptase polymerase chain reaction. The experiment was repeated three times. ∗, p < .05 compared with unmodified SMSCs. (E): Particle size distribution of SMSC‐Exos measured by Nanosizer. The experiments were repeated three times, and representative results are shown. (F): Morphology of SMSC‐Exos analyzed by transmission electron microscopy. Scale bar = 200 nm. (G): Exosome surface markers detected by Western blotting (Alix, Tsg101, <t>CD9,</t> CD63, and CD81). Three independent experiments were performed to confirm the stability of these phenomena. Abbreviations: SMSC, synovium mesenchymal stem cell; SMSC‐126, microRNA‐126‐3p‐overexpressing synovium mesenchymal stem cells.
Cd9 Protein Marker, supplied by System Biosciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd9 protein marker/product/System Biosciences Inc
Average 90 stars, based on 1 article reviews
cd9 protein marker - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Classification and modification of human SMSCs and exosomes. (A): SMSCs exhibited a spindle‐like morphology. Scale bar = 50 μm. (B): Flow cytometric analysis of cell surface markers. Blank curves represent isotype controls and solid gray curves represent test samples. (C): SMSCs displayed osteogenic, adipogenic, and chondrogenic differentiation potential. Scale bars = 50 μm (osteogenic), 20 μm (adipogenic), and 100 μm (chondrogenic). (D): mRNA levels detected by quantitative reverse‐transcriptase polymerase chain reaction. The experiment was repeated three times. ∗, p < .05 compared with unmodified SMSCs. (E): Particle size distribution of SMSC‐Exos measured by Nanosizer. The experiments were repeated three times, and representative results are shown. (F): Morphology of SMSC‐Exos analyzed by transmission electron microscopy. Scale bar = 200 nm. (G): Exosome surface markers detected by Western blotting (Alix, Tsg101, CD9, CD63, and CD81). Three independent experiments were performed to confirm the stability of these phenomena. Abbreviations: SMSC, synovium mesenchymal stem cell; SMSC‐126, microRNA‐126‐3p‐overexpressing synovium mesenchymal stem cells.

Journal: Stem Cells Translational Medicine

Article Title: Chitosan Wound Dressings Incorporating Exosomes Derived from MicroRNA‐126‐Overexpressing Synovium Mesenchymal Stem Cells Provide Sustained Release of Exosomes and Heal Full‐Thickness Skin Defects in a Diabetic Rat Model

doi: 10.5966/sctm.2016-0275

Figure Lengend Snippet: Classification and modification of human SMSCs and exosomes. (A): SMSCs exhibited a spindle‐like morphology. Scale bar = 50 μm. (B): Flow cytometric analysis of cell surface markers. Blank curves represent isotype controls and solid gray curves represent test samples. (C): SMSCs displayed osteogenic, adipogenic, and chondrogenic differentiation potential. Scale bars = 50 μm (osteogenic), 20 μm (adipogenic), and 100 μm (chondrogenic). (D): mRNA levels detected by quantitative reverse‐transcriptase polymerase chain reaction. The experiment was repeated three times. ∗, p < .05 compared with unmodified SMSCs. (E): Particle size distribution of SMSC‐Exos measured by Nanosizer. The experiments were repeated three times, and representative results are shown. (F): Morphology of SMSC‐Exos analyzed by transmission electron microscopy. Scale bar = 200 nm. (G): Exosome surface markers detected by Western blotting (Alix, Tsg101, CD9, CD63, and CD81). Three independent experiments were performed to confirm the stability of these phenomena. Abbreviations: SMSC, synovium mesenchymal stem cell; SMSC‐126, microRNA‐126‐3p‐overexpressing synovium mesenchymal stem cells.

Article Snippet: Expression of the exosomal characteristic markers Alix (1:500), CD9 (1:500), CD63 (1:1,000), CD81 (1:1,000), and TSG101 (1:500) (all from System Biosciences, Palo Alto, CA, https://www.systembio.com ) were analyzed by Western blotting.

Techniques: Modification, Reverse Transcription, Polymerase Chain Reaction, Transmission Assay, Electron Microscopy, Western Blot